- IFM to launch IFM Quattro, along with new incubator, IFM Discovery, and up to two additional subsidiaries focused on select targets of the innate immune system
- Financing is led by new investor Omega Funds, with participation from existing investors Atlas Venture and Abingworth
- Dr. Gary D. Glick to transition to role of executive chairman